These data highlight the need to identify patients with hyperglycemia, who are at high risk of adverse angiographic outcomes regardless of a history of diabetes.
Receive the the latest news, research, and presentations from major meetings right to your inbox. TCTMD ® is produced by the Cardiovascular Research Foundation ® (CRF). CRF ® is committed to igniting ...
The "Italy Contrast Media Injectors Market Outlook to 2033 - Computed Tomography (CT), Magnetic Resonance Imaging (MRI) and Angiographic Injectors" report has been added to ResearchAndMarkets.com's ...